Key points from article :
Neurona Therapeutics raised $120 million to progress cell therapies for brain diseases like epilepsy and Alzheimer's.
Their therapy uses implanted cells that release calming signals to repair faulty brain connections.
Early results in epilepsy are promising, potentially offering seizure control and memory protection.
They're also developing cells to repair a different brain structure damaged in Alzheimer's.
Genetically engineered cells are planned to deliver other helpful molecules directly to the brain.
This funding will advance clinical trials for both epilepsy and Alzheimer's, plus explore other brain diseases.
